Allopurinol

• Category :

  Pharmaceuticals and Biochemicals

• Synonyms :

  Adenock;Allopurinol;Hydroxypyrazolodpyrimidine;pyrazolo(3,4-d)pyrimidin-1-ol;4-Hydroxypyrazolo(3,4-d)-pyrimidine;1H-Pyrazolo[3,4-d]pyrimidin-4-ol;ACO;1,2-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-one;ALO;4-hydroxy-1H-pyrazolo(3,4-d)pyrimidine;

• CAS NO :

  315-30-0

• EC NO :

  206-250-9

• Molecular Formula :

  C₅H₄N₄O

• Molecular Weight :

  136.1115

• Main Specifications :

  99% up

• InChI :

  InChI=1/C5H4N4O/c10-5-3-1-8-9-4(3)6-2-7-5/h1-2H,(H2,6,7,8,9,10)

• Packing :

  1kg/bag, 5kg/bag, or as per customers’ requirements.

• Product description :

  Allopurinol used primarily in gout attack phase and the chronic phase, applied to generate too much uric acid, uricosuric allergy or is invalid, as well as urination drugs should not be used (such as renal insufficiency) of primary and secondary gout, hyperuricemia control. The drug can also be combined with uricosuric to enhance efficacy, especially in serious tophi and kidney patients is good. Allopurinol is an antigout medicine and is suitable for: 1.The treatment of chronic primary or secondary gout, but is not effective for acute gout attacks, because this product has no anti-inflammatory effect, and may increase or prolong the acute phase of inflammation. When controlling acute gout attacks, colchicine or other anti-inflammatory drugs must be applied at the same time, especially within a few months of the start of treatment; 2.Allopurinol used to treat uric acid nephropathy with or without gout symptoms; 3.Allopurinol used for repeated attacks Patients with sexual uric acid stones, to prevent the formation of stones; 4.Allopurinol used to prevent leukemia, lymphoma or other tumors in tissues secondary to urate deposition, kidney stones, etc. after chemotherapy or radiotherapy. For the uric acid stones that have been formed, it also helps to re-dissolve the stones.

• Uses :

  Allopurinol used primarily in gout attack phase and the chronic phase

• Molecular Structure :